From the research index
The paper comes from the research index. It wasn’t submitted here.
Decrease of Neuropsychiatric and Neurocognitive Side Effects Prevalence
Clinical trial record
Registered before results. Outcomes may change.
Decrease of Neuropsychiatric and Neurocognitive Side Effects Prevalence
NCT02447016
- Sponsor
- Sheba Medical Center
- Started
- 1 May 2015
- Trial ID
- NCT02447016
Abstract
The aim of this prospective, open label study is to check for differences in neuropsychiatric and neurocognitive measurements among patients that will be switched from Atripla to Eviplera among 40 patients.